Yasuyuki Seto Selected Research

Antigens

10/2020	Focal adhesion ribonucleoprotein complex proteins are major humoral cancer antigens and targets in autoimmune diseases.
5/2019	Capturing the differences between humoral immunity in the normal and tumor environments from repertoire-seq of B-cell receptors using supervised machine learning.
1/2018	Decrease in PSCA expression caused by Helicobacter pylori infection may promote progression to severe gastritis.
1/2017	Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B Cell Antigens in Human Malignancies.
2/2014	Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
12/2011	A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuyuki Seto Research Topics

Disease

88	Stomach Neoplasms (Stomach Cancer) 12/2022 - 01/2002
75	Neoplasms (Cancer) 10/2022 - 01/2002
21	Esophageal Neoplasms (Esophageal Cancer) 03/2022 - 06/2012
19	Neoplasm Metastasis (Metastasis) 12/2022 - 07/2004
15	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2009
14	Lymphatic Metastasis 07/2022 - 05/2006
13	Carcinoma (Carcinomatosis) 01/2021 - 07/2007
6	Esophageal Squamous Cell Carcinoma 07/2022 - 10/2016
6	Sarcopenia 05/2022 - 01/2020
5	Hemorrhage 08/2022 - 01/2002
5	Peritonitis 09/2019 - 10/2015
5	Ascites 08/2019 - 08/2013
4	Thyroid Neoplasms (Thyroid Cancer) 10/2022 - 05/2020
4	Infections 02/2022 - 01/2014
4	Pneumonia (Pneumonitis) 12/2021 - 10/2016
4	Weight Loss (Weight Reduction) 07/2021 - 03/2017
4	Obesity 04/2021 - 01/2018
4	Colorectal Neoplasms (Colorectal Cancer) 05/2020 - 01/2010
4	Metaplasia 01/2019 - 09/2011
4	Carcinogenesis 03/2016 - 07/2009
3	COVID-19 02/2022 - 01/2021
3	Sepsis (Septicemia) 05/2021 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2017
3	Ulcer 03/2017 - 01/2002
2	Pancreatic Fistula (Pancreatic Fistulas) 08/2022 - 01/2018
2	Residual Neoplasm 07/2021 - 01/2015
2	Neuroendocrine Carcinoma 02/2021 - 10/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 07/2019
2	Body Weight (Weight, Body) 11/2019 - 03/2017
2	Triple Negative Breast Neoplasms 01/2019 - 06/2017
2	Wounds and Injuries (Trauma) 08/2018 - 01/2008
2	Disease Progression 01/2018 - 06/2014

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2013
7	Indicators and Reagents (Reagents)IBA 02/2022 - 01/2017
6	AntigensIBA 10/2020 - 12/2011
5	AntibodiesIBA 02/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2018
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2010
5	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2010
4	Immunoglobulin G (IgG)IBA 02/2022 - 09/2011
3	taxaneIBA 12/2022 - 10/2018
3	Trastuzumab (Herceptin)FDA Link 10/2022 - 10/2016
3	Immunoglobulin M (IgM)IBA 02/2022 - 01/2021
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	Biological ProductsIBA 01/2022 - 10/2016
3	Formaldehyde (Formol)FDA Link 12/2021 - 01/2017
3	ParaffinIBA 12/2021 - 01/2017
3	Complement System Proteins (Complement)IBA 01/2021 - 01/2017
3	human ERBB2 proteinIBA 01/2019 - 10/2016
3	Pepsinogen A (Pepsinogen)IBA 01/2018 - 07/2009
3	Trefoil FactorsIBA 01/2018 - 09/2011
2	PlatinumIBA 12/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 07/2022 - 10/2009
2	Nucleocapsid ProteinsIBA 02/2022 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 10/2016
2	CytokinesIBA 03/2021 - 06/2014
2	B7-H1 AntigenIBA 02/2021 - 01/2021
2	Programmed Cell Death 1 ReceptorIBA 02/2021 - 01/2017
2	Coloring Agents (Dyes)IBA 10/2020 - 01/2014
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2020 - 12/2015
2	4-azidosalicylic acid-phosphatidylserineIBA 09/2020 - 01/2020
2	Estrogen ReceptorsIBA 01/2019 - 06/2017
2	Decitabine FDA Link 01/2019 - 01/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 04/2017
2	EnzymesIBA 11/2016 - 09/2011
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 07/2009
2	Monoclonal AntibodiesIBA 07/2015 - 07/2012

Therapy/Procedure

49	Gastrectomy 05/2022 - 07/2004
29	Therapeutics 12/2022 - 07/2007
27	Esophagectomy 07/2022 - 01/2014
18	Drug Therapy (Chemotherapy) 12/2022 - 12/2007
18	Lymph Node Excision (Lymph Node Dissection) 07/2021 - 01/2002
10	Hepatectomy 10/2021 - 05/2006
8	Operative Surgical Procedures 05/2022 - 10/2011
7	Length of Stay 08/2022 - 12/2017
6	Neoadjuvant Therapy 05/2022 - 07/2007
6	Chemoradiotherapy 07/2021 - 11/2009
6	Pancreaticoduodenectomy 10/2020 - 03/2008
5	Radiotherapy 07/2022 - 12/2007
5	Immunotherapy 12/2021 - 01/2017
5	Colectomy 05/2021 - 10/2015
4	Adjuvant Chemotherapy 12/2022 - 02/2011
3	Splenectomy 08/2022 - 07/2004
3	Operative Time 01/2019 - 01/2018
3	Laparotomy 12/2018 - 07/2008
3	Robotic Surgical Procedures 09/2017 - 09/2012
3	Lasers (Laser) 04/2016 - 01/2010
2	Appendectomy 10/2022 - 06/2022
2	Anesthesia 08/2022 - 05/2020
2	Segmental Mastectomy (Lumpectomy) 07/2022 - 01/2015
2	Surgical Instruments (Clip) 03/2022 - 01/2008
2	Thyroidectomy 01/2022 - 05/2020
2	Injections 12/2021 - 06/2020
2	Contraindications 07/2021 - 07/2008
2	Bariatric Surgery 04/2021 - 01/2018
2	Mastectomy (Mammectomy) 12/2020 - 07/2017
2	Activities of Daily Living (ADL) 01/2020 - 07/2019
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2020 - 11/2014
2	Vagotomy 01/2017 - 06/2014